More on SCYX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-264.3% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Scynexis (NQ:SCYX)
Delayed: 4.27 -0.21 (4.69%)
Prev. Close $4.48  
Open$4.44 
52 Wk High$7.29 
52 Wk Low$1.74 
Day High$4.67 
Day Low$4.23 
P/E N/A  
EPS$0.00 
Volume22,838 


Jul 8, 2026 07:57 AM Form SCHEDULE 13G/A SCYNEXIS INC Filed by: FEDERATED HERMES, INC.
Jun 30, 2026 04:10 PM Form 4 SCYNEXIS INC For: Jun 26 Filed by: Tinmouth Brian Philippe
Jun 30, 2026 04:09 PM Form 4 SCYNEXIS INC For: Jun 26 Filed by: Macdonald Guy
Jun 30, 2026 04:07 PM Form 4 SCYNEXIS INC For: Jun 26 Filed by: ANIDO ARMANDO
Jun 30, 2026 04:04 PM Form 4 SCYNEXIS INC For: Jun 26 Filed by: HASTINGS DAVID C
Jun 30, 2026 04:01 PM Form 4 SCYNEXIS INC For: Jun 26 Filed by: HANHAM ANN
Jun 30, 2026 08:02 AM Scynexis starts Phase 1 trial of SCY-770 for rare kidney disease
Jun 30, 2026 08:00 AM SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jun 26, 2026 04:02 PM Form 8-K SCYNEXIS INC For: Jun 25
May 29, 2026 04:02 PM Form 8-K SCYNEXIS INC For: May 28
View All Articles

Entities mentioned with SCYX

View All Entities